MARKET

CPRX

CPRX

Catalyst Pharmaceuticals Inc
NASDAQ
31.50
+0.08
+0.25%
After Hours: 31.39 -0.11 -0.35% 19:54 06/26 EDT
OPEN
31.44
PREV CLOSE
31.42
HIGH
31.50
LOW
31.41
VOLUME
4.07M
TURNOVER
--
52 WEEK HIGH
32.56
52 WEEK LOW
19.05
MARKET CAP
3.86B
P/E (TTM)
18.11
1D
5D
1M
3M
1Y
5Y
1D
Catalyst Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalyst Pharmaceuticals, Inc. - CPRX
Barchart · 4d ago
Catalyst Pharma Gains FTC Clearance for Angelini Merger
TipRanks · 4d ago
Catalyst Pharma says FTC grants early HSR clearance for Angelini deal
PUBT · 4d ago
Weekly Report: what happened at CPRX last week (0615-0619)?
Weekly Report · 6d ago
As corporate profit margins remain elevated, these mid-caps stand out
Seeking Alpha · 06/18 13:25
Weekly Report: what happened at CPRX last week (0608-0612)?
Weekly Report · 06/15 10:31
Catalyst Pharmaceuticals Sets July 2026 Vote on $31.50-per-Share Angelini Pharma Buyout
TipRanks · 06/08 21:27
Weekly Report: what happened at CPRX last week (0601-0605)?
Weekly Report · 06/08 10:26
More
About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing medicines for patients living with rare and difficult-to-treat diseases. The Company markets three drug products: FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone). FIRDAPSE is a treatment for people six years of age or older living with Lambert-Eaton myasthenic syndrome (LEMS). The Company, through its sub-licensee, also offers FIRDAPSE in Canada and Japan. FYCOMPA is a prescription medicine used alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older. AGAMREE is a corticosteroid with a structure that retains the potent anti-inflammatory effects of traditional corticosteroids used in Duchenne muscular dystrophy.

Webull offers Catalyst Pharmaceuticals Inc stock information, including NASDAQ: CPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPRX stock methods without spending real money on the virtual paper trading platform.